SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001829126-23-008158
Filing Date
2023-12-21
Accepted
2023-12-21 16:01:40
Documents
1
Period of Report
2023-06-28

Document Format Files

Seq Description Document Type Size
1 FORM 4/A ownership.html 4/A  
1 FORM 4/A ownership.xml 4/A 5268
  Complete submission text file 0001829126-23-008158.txt   6985
Mailing Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314
Business Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314 888-963-7881
Organicell Regenerative Medicine, Inc. (Issuer) CIK: 0001557376 (see all company filings)

IRS No.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O GELESIS, INC. 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address
Leider Harry L. (Reporting) CIK: 0001888273 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-55008 | Film No.: 231505249